Literature DB >> 8518620

Uses of heparin. Ancrod for heparin induced thrombocytopenia.

R L Soutar, J S Ginsberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8518620      PMCID： PMC1677806          DOI： 10.1136/bmj.306.6889.1410-a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Heparin-associated thrombocytopenia and thrombosis: optimal therapy with ancrod.

Authors:  C W Cole; L M Fournier; J Bormanis
Journal:  Can J Surg       Date:  1990-06       Impact factor: 2.089

2.  Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172.

Authors:  B H Chong; F Ismail; J Cade; A S Gallus; S Gordon; C N Chesterman
Journal:  Blood       Date:  1989-05-01       Impact factor: 22.113

3.  Uses of heparin.

Authors:  C N Chesterman; B H Chong
Journal:  BMJ       Date:  1993-04-03

4.  Retrospective study on complications and adverse effects of treatment with thrombin-like enzymes--a multicentre trial.

Authors:  Z S Latallo
Journal:  Thromb Haemost       Date:  1983-08-30       Impact factor: 5.249

5.  Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia.

Authors:  C Demers; J S Ginsberg; P Brill-Edwards; A Panju; T E Warkentin; D R Anderson; C Turner; J G Kelton
Journal:  Blood       Date:  1991-11-01       Impact factor: 22.113
  5 in total
  2 in total

1.  Management of heparin induced thrombocytopenia.

Authors:  H N Magnani
Journal:  BMJ       Date:  1993-07-17

2.  Heparin-induced Thrombocytopenia.

Authors:  Marie Gerhard-Herman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.